Clinical aspects of hereditary hearing loss

Genetics in Medicine

Volumn 9, Issue 7, 2007, Pages 393-408

  Kochhar, Amit ^a   Hildebrand, Michael S ^a   Smith, Richard J H ^a,b  

^a UNIVERSITY OF IOWA HEALTH CARE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Acquired hearing loss; Congenital hearing loss; Deafness; Genetics; Hereditary hearing loss; Mutation; Newborn hearing screening; Nonsyndromic hearing loss; Syndromic hearing loss

Indexed keywords

ALPORT SYNDROME; AUDIOLOGY; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; BIOTINIDASE DEFICIENCY; BRANCHIOOTORENAL SYNDROME; CONGENITAL DEAFNESS; DISEASE CLASSIFICATION; FAMILY HISTORY; GENETIC COUNSELING; GENETIC DISORDER; HEARING LOSS; HUMAN; NEUROFIBROMATOSIS; PENDRED SYNDROME; PHYSICAL EXAMINATION; PRENATAL SCREENING; REFSUM DISEASE; REVIEW; STICKLER SYNDROME; USHER SYNDROME; WAARDENBURG SYNDROME;

COCHLEA; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; HEARING LOSS; HUMANS; LANGUAGE DEVELOPMENT; PATIENT EDUCATION; PROSTHESES AND IMPLANTS; TERMINOLOGY;

EID: 34547749906     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3180980bd0     Document Type: Review

References (87)

1. Toriello HV, Reardon W, Gorlin RF, editors. Hereditary hearing loss and its syndromes, 2nd ed. New York: Oxford University Press, 2004.
2. Van Camp G, Smith RJH. Hereditary Hearing Loss Homepage, 2003. http://webh01.ua.ac.be/hhh/. Accessed 24 January 2007.
3. Guide for the evaluation of hearing handicap. JAMA 1979;241:2055-2059.
4. Northern JL, Downs M. Hearing in children. Baltimore: Lippincott, Williams, and Wilkins, 2002.
5. Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci 1991;630:16-31.
6. White KR. The current status of EHDI programs in the United States. Ment Retard Dev Disabil Res Rev 2003;9:79-88.
7. Marazita ML, Ploughman LM, Rawlings B, Remington E, et al. Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am J Med Genet 1993;46:486-491.
8. Cohen MM, Gorlin RJ. Epidemiology, etiology, and genetic patterns. In: Gorlin RJ, Toriello HV, Cohen MM, editors. Hereditary hearing loss and its syndromes. New York: Oxford Press, 1995:9-21.
9. Green GE, Scott DA, McDonald JM, Woodworth GG, et al. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA 1999;281:2211-2216.
10. Fischel-Ghodsian N. Genetic factors in aminoglycoside toxicity. Ann N Y Acad Sci 1999;884:99-109.
11. Harris S, Ahlfors K, Ivarsson S, Lernmark B, et al. Congenital cytomegalovirus infection and sensorineural hearing loss. Ear Hear 1984;5:352-355.
12. Hicks T, Fowler K, Richardson M, Dahle A, et al. Congenital cytomegalovirus infection and neonatal auditory screening. J Pediatr 1993;123:779-782.
13. Schildroth AN. Congenital cytomegalovirus and deafness. Am J Audiol 1994;3:27-38.
14. Ogawa H, Baba Y, Suzutani T, Inoue N, et al. Congenital cytomegalovirus infection diagnosed by polymerase chain reaction with the use of preserved umbilical cord in sensorineural hearing loss children. Laryngoscope 2006;116:1991-1994.
15. Gates G, Mills J. Presbycusis. Lancet 2005;366:1111-1120.
16. Guilford P, Ben Arab S, Blanchard S, Levilliers J, et al. Joint Committee on Infant Hearing; American Academy of Audiology; American Academy of Pediatrics; American Speech-Language-Hearing Association; Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Year 2000 position statement: principles and guidelines for early hearing detection and intervention programs. J Pediatr 2000;106:798-817.
17. Baldwin CT, Hoth CF, Amos JA, da-Silva EO, et al. An exonic mutation in HuP2 paired domain gene causes Waardenburg's syndrome. Nature 1992;355:637-638.
18. Tassabehji M, Read AP, Newton VE, Harris R, et al. Waardenburg's syndrome patients have mutations in the human homologue of Pax-3 paired box gene. Nature 1992;355:635-636.
19. Hoth CF, Milunsky A, Lipsky N, Sheffer R, et al. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am J Hum Genet 1993;52:455-462.
20. Tassabehji M, Newton VE, Read AP. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 1994;8:251-255.
21. Sánchez-Martín M, Rodríguez-García A, Pérez-Losada J, Sagrera A, et al. SLUG (SNAI2) deletions in patients with Waardenburg disease. Hum Mol Genet 2002;11:3231-3236.
22. Edery P, Attie T, Amiel J, Pelet A, et al. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat Genet 1996;12:442-444.
23. Hofstra RM, Osinga J, Tan-Sindhunata G, Wu Y, et al. A homozygous mutation in the endothelin-3 gene associated with a combines Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat Genet 1996;12:445-447.
24. Pingault V, Bondurand N, Kuhlbrodt K, Goerich DE, et al. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 1998;18:171-173.
25. Melnick M, Bixler D, Silk K, Yune H, et al. Autosomal dominant branchiootorenal dysplasia. Birth Defects Orig Artic Ser 1975;5:121-128.
26. Fraser FC, Ling D, Clogg D, Nogrady B. Genetic aspects of the BOR syndromebranchial fistulas, ear pits, hearing loss, and renal anomalies. Am J Med Genet 1978;2:241-252.
27. Heimler A, Lieber E. Branchio-Oto-Renal syndrome: reduced penetrance and variable expressivity in four generations of a large kindred. Am J Med Genet 1986;25:15-27.
28. Konig R, Fuchs S, Dukiet C. Branchio-oto-renal (BOR) syndrome: variable expressivity in a five-generation pedigree. Eur J Pediatr 1994;153:446-450.
29. Stratakis CA, Lin J-P, Rennert OM. Description of a large kindred with autosomal dominant inheritance of branchial arch anomalies, hearing loss and ear pits, and exclusion of the branchio-oto-renal (BOR) syndrome gene locus (chromosome 8q13.3). Am J Med Genet 1998;79:209-214.
30. Ruf RG, Xu PX, Silvius D, Otto EA, et al. SIX1 mutations cause Branchio-Oto-Renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A 2004;101:8090-8095.
31. Kalatzis V, Sahly I, El Amraoui A, Petit C. Eya1 expression in the developing ear and kidney: towards the understanding of the pathogenesis of Branchio-Oto-Renal (BOR) syndrome. Dev Dyn 1998;213:486-499.
32. Xu PX, Zheng W, Huang L, Maire P, et al. Six1 is required for the early organogenesis of mammalian kidney. Development 2003;130:3085-3094.
33. Zheng W, Huang L, Wei ZB, Silvius D, et al. The role of Six1 in mammalian auditory system development. Development 2003;130:3989-4000.
34. Williams CJ, Ganguly A, Considine E, McCarron S, et al. A-2àG transition at the 3′ acceptor splice site of IVS17 characterizes the COL2A1 gene mutation in the original Stickler syndrome kindred. Am J Med Genet 1996;63:461-467.
35. Richards AJ, Yates JR, Williams R, Payne SJ, et al. A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in alpha 1 (XI) collagen. Hum Mol Genet 1996;5:1339-1343.
36. Vikkula M, Mariman EC, Lui VC, Zhidkova NI, et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 1995;80:431-437.
37. Wilkin DJ, Mortier GR, Johnson CL, Jones MC, et al. Correlation of linkage data with phenotype in eight families with Stickler syndrome. Am J Med Genet 1998;80:121-127.
38. Yohay K. Neurofibromatosis types 1 and 2. Neurologist 2006;2:86-93.
39. National Institutes of Health Consensus Development Conference. Neurofibromatosis: conference statement. Arch Neurol 1988;45:475-478.
40. Phelps PD, Coffey RA, Trembath RC, Luxon LM, et al. Radiological malformations of the ear in Pendred syndrome. Clin Radiol 1998;53:268-273.
41. Reardon W, O'Mahoney CF, Trembath R, Jan H, et al. Enlarged vestibular aqueduct: a radiological marker of Pendred syndrome, and mutations of the PDS gene. QJM 2000;93:99-104.
42. Newton VE. Aetiology of bilateral sensori-neural hearing loss in young children. J Laryngol Otol Suppl 1985;10:1-57.
43. Arnos KS, Cunningham M, Israel J, Marazita ML. Innovative approach to genetic counseling services for the deaf population. Am J Med Genet 1992;44:345-351.
44. Rosenberg T, Haim M, Hauch AM, Parving A. The prevalence of Usher syndrome and other retinal dystrophy-hearing impairment associations. Clin Genet 1997;51:314-321.
45. Kimberling WJ, Moller CG, Davenport SL, Lund G, et al. Usher syndrome: clinical findings and gene localization studies. Laryngoscope 1989;99:66-72.
46. Neyroud N, Tesson F, Denjoy I, Leibovici M, et al. A novel mutation in the potassium channel gene KVLTQ1 causes Jervell Lange-Nielsen cardioauditory syndrome. Nat Genet 1997;15:186-189.
47. Schulze-Bahr E, Wang Q, Wedekind H, Haverkamp W, et al. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet 1997;17:267-268.
48. Wolf B, Spencer R, Gleason T. Hearing loss is a common feature of symptomatic children with profound biotinidase deficiency. J Pediatr 2002;140:242-246.
49. Heller AJ, Stanley C, Shaia WT, Sismanis A, et al. Localization of biotinidase in the brain: implications for its role in hearing loss in biotinidase deficiency. Hear Res 2002;173:62-68.
50. Wander RJA, Jacobs C, Skjeldal OH. Refsum disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. New York: McGraw Hill, 1995:3301-3321.
51. van den Brink DM, Wanders RJ. Phytanic acid: production from phytol, its breakdown and role in human disease. Cell 2006;63:1752-1765.
52. Govan J. Ocular manifestations of Alport's syndrome: a hereditary disorder of basement membranes? Br J Ophthalmol 1983;67:493-503.
53. Barker DF, Hostikka SL, Zhou J, Chow LT, et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990;248:1224-1227.
54. Mohr J, Mageroy K. Sex-linked deafness of a possibly new type. Acta Genet Statist Med 1960;10:54-62.
55. Tranebjaerg L, Schwartz C, Eriksen H, Andreasson S, et al. A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22. J Med Genet 1995;32:257-263.
56. Jin H, May M, Tranebjaerg L, Kendall E, et al. A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nat Genet 1996;14:177-180.
57. Koehler CM, Leuenberger D, Merchant S, Renold A, et al. Human deafness dystonia syndrome is a mitochondrial disease. Proc Natl Acad Sci U S A 1999;96:2141-2146.
58. Usami S, Abe S, Akita J, Namba A, et al. Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet 2000;37:38-40.
59. Majamaa K, Moilanen JS, Uimonen S, Remes AM, et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes: prevalence of the mutation in an adult population. Am J Hum Genet 1998;63:447-454.
60. Kadowaki T, Kadowaki H, Mori Y, Tobe K, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994;330:962-968.
61. Cremers CW, Marres HA, van Rijn PM. Nonsyndromal profound genetic deafness in childhood. Ann N Y Acad Sci 1991;630:191-196.
62. Van Camp G, Willems PJ, Smith RJ. Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet 1997;60:758-764.
63. Zelante L, Gasparini P, Estivill X, Melchionda S, et al. Connexin26 mutations associated with the most common form of non- syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet 1997;6:1605-1609.
64. Estivill X, Fortina P, Surrey S, Rabionet R, et al. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 1998;351:394-398.
65. Kelley PM, Harris DJ, Comer BC, Askew JW, et al. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet 1998;62:792-799.
66. Scott DA, Kraft ML, Carmi R, Ramesh A, et al. Identification of mutations in the connexin 26 gene that cause autosomal recessive nonsyndromic hearing loss. Hum Mutat 1988;11:387-394.
67. Zbar RI, Ramesh A, Srisailapathy CR, Fukushima K, et al. Passage to India: the search for genes causing autosomal recessive nonsyndromic hearing loss. Otolaryngol Head Neck Surg 1998;118:333-337.
68. Snoeckx RL, Huygen PL, Feldmann D, Marlin S, et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet 2005;77:945-957.
69. Vore AP, Chang EH, Hoppe JE, Butler MG, et al. Deletion of and novel missense mutation in POU3F4 in 2 families segregating X-linked nonsyndromic deafness. Arch Otolaryngol Head Neck Surg 2005;131:1057-1063.
70. Fischel-Ghodsian N. Mitochondrial mutations and hearing loss: paradigm for mitochondrial genetics. Am J Hum Genet 1998;62:15-19.
71. Hone SW, Smith RJ. Medical evaluation of pediatric hearing loss: laboratory, radiographic, and genetic testing. Otolaryngol Clin North Am 2002;35:751-764.
72. Zalzal GH, Shott SR, Towbin R, Cotton RT. Value of CT scan in the diagnosis of temporal bone diseases in children. Laryngoscope 1986;96:27-32.
73. Bamiou D, Phelps P, Sirimanna T. Temporal bone computed tomography findings in bilateral sensorineural hearing loss. Int J Pediatr Otorhinolaryngol 1999;51:91-99.
74. Vore AP, Chang EH, Hoppe JE, Butler MG, et al. Deletion of and novel missense mutation in POU3F4 in 2 families segregating X-linked nonsyndromic deafness. Arch Otolaryngol Head Neck Surg 2005;131:1057-1063.
75. Middleton A, Hewison J, Mueller RF. Attitudes of deaf adults toward genetic testing for hereditary deafness. Am J Hum Genet 1998;63:1175-1180.
76. Arnos KS. The implications of genetic testing for deafness. Ear Hear 2003;24:324-331.
77. Arnos KS, Israel J, Cunningham M. Genetic counseling of the deaf - medical and cultural considerations. Ann N Y Acad Sci 1992;630:212-222.
78. Mohr P, Feldman JJ, Dunbar JL. The societal costs of severe to profound hearing loss in the United States. Int J Technol Assess Health Care 2000;16:1120-1135.
79. Downs MP, Yoshinaga-Itano C. The efficacy of early identification and intervention for children with hearing impairment. Pediatr Clin North Am 1999;46:79-87.
80. White KR. National Center for Hearing Assessment and Management website, 2006. http://www.infanthearing.org. Accessed 10 February 2007.
81. Yoshinaga-Itano C, Seday A, Coulter DK, Mehl AL. Langauge of early- and lateridentified children with hearing loss. J Pediatr 1998;102:1161-1171.
82. Hone SW, Smith RJ. Medical evaluation of pediatric hearing loss: laboratory, radiographic, and genetic testing. Otolaryngol Clin North Am ;200235:751-764.
83. Norris VW, Arnos KS, Hanks WD, Xia X, et al. Does universal newborn hearing screening identify all children with GJB2 (connexin 26) deafness? Penetrance of GJB2 deafness. Ear Hear 2006;27:732-741.
84. Minoda R, Izumikawa M, Kawamoto K, Raphael Y. Strategies for replacing lost cochlear hair cells. Neuroreport 2004;15:1089-1092.
85. Shou J, Zheng JL, Gao WQ. Robust generation of new hair cells in mature mammalian inner ear by adenoviral expression of Hath1. Mol Cell Neurosci 2003;23:169-179.
86. Kawamoto K, Ishimoto S, Minoda R, Brough DE, et al. Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci 2003;23:4395-4400.
87. Smith R, Bale J, White K. Sensorineural hearing loss in children. Lancet 2005;365:879-890.